SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARADIGM CORP. ARDM -- Ignore unavailable to you. Want to Upgrade?


To: Area51 who wrote (203)5/5/2004 10:53:42 PM
From: keokalani'nui  Read Replies (1) | Respond to of 255
 
There is just no way of knowing. I'm convinced not even novo knows. But the lead suspect, if proven, will imo be the end of the drug.

You can be also sure that it's in trouble since only a few more months and they would have had the 24-mo safety data, but they stopped the trial anyway. Would fda require 24-month data for a T2-only NDA?

You are right about the payoff however.

I don't know so much about science, btw. Could save you or make you some money knowing that. ;-)